BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

10x Genomics Secures Permanent Injunction Against Bruker’s GeoMx Products Following Patent Infringement Verdict

10x Genomics, Inc. , a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for...

December 24, 2024 | News

Vertex Announces FDA Approval of ALYFTREK™: A Once-Daily CFTR Modulator for Cystic Fibrosis Patients Aged 6 and Older

ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not re...

December 23, 2024 | News

Innovent Biologics Secures NMPA Approval for DOVBLERON®, a Next-Generation Precision Therapy for ROS1-Positive NSCLC

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 23, 2024 | News

YolTech Therapeutics Advances YOLT-201 Gene-Editing Therapy to Dose-Expansion Phase in ATTR Amyloidosis Clinical Trial

YolTech Therapeutics announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editin...

December 23, 2024 | News

Illumina Joins Forces with Macrogen Consortium to Drive Korea's National Bio Big Data Project

Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium. Macrogen a global healthcare company that specializes in pre...

December 23, 2024 | News

MGI Partners with Sabin Group to Advance Genetic Sequencing and Personalized Medicine in Brazil

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, has recently partnered with ...

December 20, 2024 | News

Certa Therapeutics Strengthens Asia-Pacific Leadership with Acquisition of Melbourne-Based OccuRx to Advance GPR68-Driven Fibrotic Disease Therapies

Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acqu...

December 19, 2024 | News

Shanghai’s Juncell Therapeutics Opens State-of-the-Art TIL Manufacturing Facility at Anting International Medical Industry Park

Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lym...

December 19, 2024 | News

Australia’s Clarity Pharmaceuticals Expands Pipeline with Novel FAP-Targeted Radiopharmaceutical

Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of...

December 19, 2024 | News

Lonza Opens State-of-the-Art R&D Facility in Slough, UK to Drive Biologics Innovation

Lonza, a global leader in biotechnology and pharmaceutical manufacturing, is proud to announce the opening of its new state-of-the-art research and develop...

December 19, 2024 | News

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Access to Advanced Sequencing Services

Complete Genomics, a San Jose, California based genomics tools manufacturer, announced Framingham, Massachusetts based Eurofins C...

December 18, 2024 | News

Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...

December 17, 2024 | News

SK Biopharmaceuticals and ProEn Therapeutics to Develop Two Radiopharmaceutical Candidates by 2027 Using ArtBody™ Platform

SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder ...

December 17, 2024 | News

Innovent Biologics and Lilly Collaborate to Bring Novel BTK Inhibitor Jaypirca® to Mainland China

Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...

December 16, 2024 | News

Stay Connected